90% of the HHT cases are associated with heterozygous mutations of ACVRL1 or ENG genes, that respectively encode a bone morphogenetic protein receptor (activin receptor-like kinase 1, ALK1) and a co-receptor named endoglin. Here, ACVRL1 is linked to hereditary hemorrhagic telangiectasia.